Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily C Martin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Yale Journal of Biology and Medicine|December 27, 2016
CBX Chromodomain Inhibition Enhances Chemotherapy Response in Glioblastoma MultiformeKatelyn E Connelly, Emily C Martin, Emily C Dykhuizen
Journal of Alternative and Complementary Medicine (New York, N.Y.)|May 15, 2015
Impact of a Yoga Intervention on Physical Activity, Self-Efficacy, and Motivation in Women with PTSD SymptomsEmily C Martin, Alexandra M Dick, Erica R Scioli-Salter, et al.
Neuro-Oncology|April 4, 2003
NeurolymphomatosisJoachim M Baehring, Denise Damek, Emily C Martin, et al.
Neurology|February 9, 2024
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 TrialDouglas L Arnold, Colm Elliott, Emily C Martin, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 28, 2012
DASH to wellness: emphasizing self-regulation through e-health in adults with prehypertensionAshley E Dorough, Richard A Winett, Eileen S Anderson, et al.
Archives of Neurology|June 15, 2007
Neuropsychological measures in normal individuals that predict subsequent cognitive declineDeborah Blacker, Hang Lee, Alona Muzikansky, et al.
Clinical and Translational Science|October 27, 2019
Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy VolunteersAndreas Becker, Emily C Martin, David Y Mitchell, et al.
Pain Physician|July 26, 2016
Effectiveness of Splanchnic Nerve Neurolysis for Targeting Location of Cancer Pain: Using the Pain Drawing as an Outcome VariableDiane M Novy, Mitchell P Engle, Emily A Lai, et al.
JMIR Cancer|April 15, 2017
Interest in Health Behavior Intervention Delivery Modalities Among Cancer Survivors: A Cross-Sectional StudyEmily C Martin, Karen Basen-Engquist, Matthew G Cox, et al.
The New England Journal of Medicine|May 11, 2019
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple SclerosisXavier Montalban, Douglas L Arnold, Martin S Weber, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Yale Journal of Biology and Medicine|December 27, 2016
CBX Chromodomain Inhibition Enhances Chemotherapy Response in Glioblastoma MultiformeKatelyn E Connelly, Emily C Martin, Emily C Dykhuizen
Journal of Alternative and Complementary Medicine (New York, N.Y.)|May 15, 2015
Impact of a Yoga Intervention on Physical Activity, Self-Efficacy, and Motivation in Women with PTSD SymptomsEmily C Martin, Alexandra M Dick, Erica R Scioli-Salter, et al.
Neuro-Oncology|April 4, 2003
NeurolymphomatosisJoachim M Baehring, Denise Damek, Emily C Martin, et al.
Neurology|February 9, 2024
Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 TrialDouglas L Arnold, Colm Elliott, Emily C Martin, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|November 28, 2012
DASH to wellness: emphasizing self-regulation through e-health in adults with prehypertensionAshley E Dorough, Richard A Winett, Eileen S Anderson, et al.
Archives of Neurology|June 15, 2007
Neuropsychological measures in normal individuals that predict subsequent cognitive declineDeborah Blacker, Hang Lee, Alona Muzikansky, et al.
Clinical and Translational Science|October 27, 2019
Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration-QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy VolunteersAndreas Becker, Emily C Martin, David Y Mitchell, et al.
Pain Physician|July 26, 2016
Effectiveness of Splanchnic Nerve Neurolysis for Targeting Location of Cancer Pain: Using the Pain Drawing as an Outcome VariableDiane M Novy, Mitchell P Engle, Emily A Lai, et al.
JMIR Cancer|April 15, 2017
Interest in Health Behavior Intervention Delivery Modalities Among Cancer Survivors: A Cross-Sectional StudyEmily C Martin, Karen Basen-Engquist, Matthew G Cox, et al.
The New England Journal of Medicine|May 11, 2019
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple SclerosisXavier Montalban, Douglas L Arnold, Martin S Weber, et al.
Pageof 2